Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Family Health History
    • Teach Jewish Genetics
    • For Medical Professionals
    • Personal Stories
    • Blog
    • Events
  • Donate
  • Get Screened

Congenital Adrenal Hyperplasia (CYP11B1-Related)

11-beta-hydroxylase-deficient congenital adrenal hyperplasia (11b-OHD CAH) impacts the production of important hormones that leads to excess production of a male sex hormone called androgen.

The ‘classic’ form of 11b-OHD CAH is the most severe and may impact the development of a female newborn’s external genitalia causing it to not be clearly female or male in origin (ambiguous genitalia). Males and females with 11b-OHD-CAH may develop early puberty, exaggerated development of male characteristics (virilization), and infertility. Additionally, many individuals will develop high blood pressure (hypertension) in childhood.

The ‘non-classic’ form of 11b-OHD CAH is less severe and does not lead to ambiguous genitalia in female newborns. While many people with the non-classic form never come to medical attention, others may have shorter than average stature and females may develop abnormal menstruation, masculinization of some features, and infertility.

Both forms of 11b-OHD CAH are treatable and treatments vary depending on the severity of symptoms that an individual presents with.

This condition is caused by pathogenic (disease-causing) variants in the CYP11B1 gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. For example, individuals of Sephardic Jewish descent have a 1 in 40 chance to be a carrier. 

Resources:  

Medline Plus

Living with CAH

Revised July 2023

Share this
Tweet this
Email this

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

Twitter/X
About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2023 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top